Inflamapls
Monthey
About Inflamapls
Inflamalps is a biopharmaceutical company established in Valais, Switzerland. Their mission is ‘’to discover and develop novel medicines to treat inflammation with a focus on chronic inflammatory diseases of the eye and of the skin” Their team comprises experienced pharmaceutical industry and biotechnology company managers with significant track record in drug development, management and financing. Their focus is on developing topical treatments for inflammation-mediated diseases in ophthalmology and dermatology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.8M
- Funding stage: Private Equity
- Last round: Private Equity (Aug 2015)
- Website: inflamalps.com
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/inflamapls-2850835 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.